Analysts’ Opinions Are Mixed on These Conglomerates Stocks: NCI Building (NYSE: NCS) and Adient plc (NYSE: ADNT)

By Carrie Williams

Companies in the Conglomerates sector have received a lot of coverage today as analysts weigh in on NCI Building (NCSResearch Report) and Adient plc (ADNTResearch Report).

NCI Building (NCS)

In a report issued on May 9, Matthew Bouley from Barclays maintained a Hold rating on NCI Building, with a price target of $6. The company’s shares closed on Friday at $6.01, close to its 52-week low of $5.39.

According to TipRanks.com, Bouley is a 3-star analyst with an average return of 5.1% and a 54.1% success rate. Bouley covers the Industrial Goods sector, focusing on stocks such as Continental Building Products, Builders Firstsource, and BMC Stock Holdings.

The word on The Street in general, suggests a Moderate Sell analyst consensus rating for NCI Building with a $5.67 average price target.

See today’s analyst top recommended stocks >>

Adient plc (ADNT)

Barclays analyst Brian Johnson maintained a Buy rating on Adient plc on May 8 and set a price target of $28. The company’s shares closed on Friday at $21.44.

According to TipRanks.com, Johnson is a 2-star analyst with an average return of 0.4% and a 50.7% success rate. Johnson covers the Industrial Goods sector, focusing on stocks such as Magna International, American Axle, and Visteon Corp.

The word on The Street in general, suggests a Hold analyst consensus rating for Adient plc with a $24.67 average price target, a 15.1% upside from current levels. In a report issued on May 1, UBS also maintained a Buy rating on the stock with a $32 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.